Westport Headache Institute, 1 Turkey Hill Road South, Suite 201, Westport, CT, USA, 06880.
Integrative Headache Medicine of New York, New York, NY, 10016, USA.
Curr Pain Headache Rep. 2024 Apr;28(4):195-203. doi: 10.1007/s11916-024-01212-y. Epub 2024 Jan 29.
Trigeminal neuralgia (TN) and trigeminal autonomic cephalalgias (TACs) are both painful diseases which directly impact the branches of the trigeminal nerve, which supply the face. Patients who have experienced adverse effects, have not responded to mainstream treatments, or have a personal preference for nonmedication options, often turn to complementary and integrative medicine (CIM). The aim of this review is to discuss the efficacy and safety of CIM therapies available for the treatment of TN and TACs.
Not only are there limited therapeutic options for TN and TAC patients, but also is there a proportion of patients who are intolerant to standard medical treatments. Recent findings have illustrated that 86% of patients with headache disorders utilize CIM modalities in combination with mainstream medical therapy. CIM modalities can be helpful for these diseases and have primarily been studied in combination with standard medical therapy. There is limited evidence for CIM and behavioral therapies in managing these conditions, and more research is needed to confirm which therapies are safe and effective.
三叉神经痛(TN)和三叉神经自主神经性头痛(TACs)均为累及三叉神经分支的疼痛性疾病,这些分支供应面部。经历过不良反应、对主流治疗无反应或偏好非药物治疗选择的患者,常转而采用补充和整合医学(CIM)治疗。本文综述的目的是讨论 CIM 治疗方法对 TN 和 TAC 治疗的疗效和安全性。
TN 和 TAC 患者的治疗选择有限,且有一部分患者不耐受标准的药物治疗。最近的研究表明,86%的头痛障碍患者将 CIM 疗法与主流医学治疗联合应用。CIM 疗法对这些疾病可能有一定的疗效,且主要与标准医学治疗联合进行研究。CIM 和行为疗法在这些疾病的治疗中证据有限,需要更多的研究来证实哪些疗法是安全有效的。